Quarterly report [Sections 13 or 15(d)]

Net Loss per Share Attributable to Common Stock - Schedule of Outstanding Shares of Common Stock Equivalents (Details)

v3.25.1
Net Loss per Share Attributable to Common Stock - Schedule of Outstanding Shares of Common Stock Equivalents (Details) - shares
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Stock options    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents (in shares) 147,707 147,707
Non-vested restricted stock awards    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents (in shares) 362,561 1,246,528
Non-vested restricted stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents (in shares) 2,533,310 2,631,384
Common stock warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents (in shares) 240,100 240,100
Convertible debt    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock equivalents (in shares) 1,759,804 583,333